on it evening. X value more joining the call. you headline results and of Tonight, pillars Good about to handing outlook. for John the financials Thanks to creation and our update go before through shareholder quarter I'll for the our speak
EBITDA rate year adjusted range year-end exit our Evolent XXXX second delivered XXXX revenue in target. just We're quarter. our above our while our profitability for confidence the expected full million we're our in within also anticipated run came $XXX range, Today, reiterating updating guidance.
to a we the for year number our perspective, put To and the of updates important today. results have share outlook in
medical Performance with of to the we this in of noted disease. higher-than-expected a first Suite few due year, prevalence higher First, primarily quarter markets costs recall
allows customers. from pleased regarding update Today, Performance We Suite on us also capitation update reflect to changes. to these that progress rate contracting our increases we're these rates to you model our noted our
with annualized partners in which we aligned an will $XX our have contribute on rates, basis. expect Specifically, we on million approximately revenue new additional
to XXXX. million capture this We rate approximately of expect $XX benefit in
partnership balance an are the over rate dynamics and the have under correct for of on Based increases. our where payers XXXX prioritized XXXX environment setting pressure, rates retrospective for they with the we in
million we retrospectively. Given the as of run our have rate high well XXXX setup reaching exit than the that, economic EBITDA as and majority target in $XXX year-end XXXX the we but increases not the slightly adjusted these in XXXX. anticipate quarter in of benefit came in begin of a third midpoint, strong to lower of confidence rate now for
to underscores importantly, creation believe customers. More our value clearly solutions we this delivered our fundamental outcome the
by line With respect and our to in March. leading noted suggested our overall expectations utilization in were with QX the expenses elevated with consistent levels QX, in performance same previously suggesting suite, QX. indicators saw We utilization decline these trends indicators in improvement into were for leading potential
improving neither consistent adjusted However, margin is, stable, consistent our and deteriorating run our trend assuming levels. baseline our fourth That remain rate, utilization with maturation to EBITDA assumes $XXX historical improvements levels normal will and achieve assuming are trend nor to third year with experience. exit we quarter million we full are guide QX be
historical moment, by To margin the levels. there course million and the pace end quarterly year. detail the outperform achieve end our we approximately utilization return trends to see will John or expect we range EBITDA need $X maturation, drive to a of to As maturation or top our in is increased normal slightly of XXXX higher, margin adjusted
XXXX average million reaching remain levels utilization we have even the to by rate at effect if levels. high confidence increases trends However, the $XXX rate because return EBITDA, December the are run XXXX XXXX, in in exit and fully don't XX,
in Regarding believe through earnings this mirror. the the is have we quarter, second captured now Medicaid of and rearview we process issue our this redeterminations, and revenue the impact substantially in
Finally, $XX Performance I'm closing our and with today agreements in pleased to revenue our EBITDA announce over rate million new run go-get out quarter, X Services, across Suite and bookings annualized Technology new and second new million the business Services, from revenue the latter $XXX Tech towards adding target.
quarters to a the improve margins EBITDA each we within and in these the adjusted of enterprise today. as factors, together, confidence Taken range of the provided Suite of significantly and result have Performance our remaining for XXXX path
Evaluating feel today, where about the continue I to stands business excited Evolent's future.
demand continue the high for we reflective believe our to strong the is see which payers from pipeline, solutions of leading around We a country.
market We have balance portfolio cross-sell revenue $XX and attractive across types fees risk. consists of and across customer different of We over $XXX our an and and billion addressable opportunity. sizes billion believe models
me With to that, the let turn results.
X a redeterminations. million driven. Second decrease organically averaged members an of all Medicaid quarter was XXXX year-over-year members, modest We revenue anticipated products in a unique for per $XXX.X with $XX.X million total deployed sequential million to of product XX.X%, member average totaling growth quarter the XX.X due of unique
position start not for majority was quarter towards the former outflow our to adjusted cash ended cash in for anticipated the the NIA. the We lower QX, million. of with to of range, increase equivalents $XX owner quarter $XXX the recognize in and $XX of a of million of after EBITDA cash Given that million earn-out we'll totaling part rate the the QX the strong in and
will growth plans X country. exciting and X we million organic in seeing Performance expansions to Ohio annual to pillars an the Suite add our and Technology in to approximately update new customer, creation, Specialty X they're among agreements, Medicaid traction agreements X for In Wisconsin are first new Services. the today growing value Specialty Performance months. new go million the Suite Blue's you shareholder Of we $XX X and our The commercial revenue Performance for over I on existing of are live Technology and X are Services, We're and want in for announcing Suite $XX across coming revenue. and and are growth. that expected now around anticipate Turning revenue
RFP Technology Evolent won X to This NIA our care as Blue provide of services of solution and an we an In the their to across services X Blue plan customer over the country. and a largest the medical provide oncology, selected was comprehensive well in as Cross Services radiation existing for plans Shield quarter, and million oncology members. X navigation
of be this the expect also under Evolent announced will care We May. Careology the umbrella in deployment product navigation first our
client's business existing and lines, MSK and to Technology commercial. solutions a membership, including of Secondly, plan we for expansion Blue Services, secured Medicare Shield beyond with Medicaid Midwest within existing significant services this Cross line Blue the expanding
remaining total We these to us annual revenue agreements million they agreements go approximately announced revenue contribute live, agreements new more expect new to cycle $XX towards these with out in the a and close today our $XXX for brings exit go-get sales bookings rate. XXXX to of new revenue run go. The million quarter XX when X X
first a This first We number national several One worth X dozen during medical time to Recall, health radiation rolled Services time out large-scale we February, our and deployment operations. implemented the announced solution Technology across highlighting go-live. national implementation surgical we we agreement full XX-state already go-lives a oncology, and to was solution successful this the in states. example quarter. of and where basis oncology marked oncology national Turning completed and provide the and plan. large of on a back implementation our surgical we
national other solutions. a In addition, One for Midwest. in Evolent partners an of also the with with in imaging Technology our our the had we client early Specialty with to quarter was implementation and successful successful existing rollout highlight cross-sell of the first X Services large-scale
radiation X.X of members all business. as as major lines well X New cardiology products included for medical and over across oncology million interventional
to complex continue supporting scale be our pleased services made team solutions progress and has of implementations. We increasingly with higher and the in
management to see align significant and meaningful the high-cost, improve to us plans clear where to health speaking that patients drive and Looking higher for demand care care. country, provide evolving management growth lower and complex abrasion We limitations advanced for utilization is solutions condition increasingly health traditional We these continue providers, strategies the rapidly anticipate headed, need with at to of to across we that seems quality manage solutions. sales providing beyond with moving And specialties. we medical satisfaction line Evolent. the payers effective with top it understand can pipeline, believe
Taken positioning strong we're a advantage differentiated our and growth year highly together, competitive setup and the remain optimistic for XXXX. in regarding
Let's operating to now profitability. of second expanding turn priority our
clinical on real ability share customers. our our are more the drive in life than examples to like clinical Our like value our to market. profitability creation anyone our value of looks what I'd a else built few value in for and proposition
located We country this in specialists scorecarding of directly higher the low-value alternative First, we leads in decline peer-to-peer work in a Southeast, of models, and which Suite direct cancer achieved using the X XX% drove breadth largest designated and quality in the engagement. community-based full payment our lower Performance model, cost. the regimens, to with result our
our clinical of we cardiology able Suite and could in be year using interventional medical creation in an in of medical costs optimal cardiology in XX% implementation were found therapy. a state and Performance example drive X which Another another value to decrease management guideline-directed the
is patients. scalable models. the financial quality achievable drive value for approach results our improve demonstrate also can these examples traditional what way beyond care Importantly, of These far through
discussions approach and clinician aisles. engagement payment our In fact, of peer-to-peer alternative believe models help we the as strategies such reduce implementing
for X based believe should in how work peer-to-peer of example, a XX% we denial health consultations. demonstrated avoidance Midwestern on this For is rate high-quality over state, We care care. complex recently
about but with the utilization and This associated the Our tape the avoids believe, conversations red model. treating frustration delays, model, having we the data-driven for experience the physicians improved world-class payer experts traditional management right thoughtful, with care also patient.
Let's are AI across turn of platform about a closing most to It's operating Machinify the and were the time our search to consistent and activities most June, found Machinify the be specialty talk technology our condition transaction We're technologies allocation. AI and for pleased our with our relevant back vision deployed in Machinify by and to competing the products. rapidly our disciplined and integration a of We acquired good product ramping to to after that we comprehensive capital We the the announced implementation advanced and announce third team portfolio. of efficiencies. management. technology principle
Evolent. of we've benefits reminder, As immediate to technology a X this described
scale teams, to growth, for in which of believe turn to streamline enable top our to work our leverage operating incremental expert of absorb this a drive deliver at should clinician their will with up the deployments our staff demonstrated ahead. growth year Machinify will this spend in XX% forecasted about in $XXX with on review years time. large to Evolent technology a continued payer, rapid the has First, the reduction in value we license, clinical and clinical Using workflow them million members Evolent. meaningful
as plan This the enabling partners the to customers is Second to long-tail Evolent can the their our long-tail we one-stop to focus, clients to policy. solution, time. to while product provides continues including benefit for a an authorizations believe, inpatient admission not serve as our prospects. more outsourced reviews, to in-house require holistic basis. medical first Machinify of complex The we with specialties for specialties a and staff, for product specialties payer health partner and payers be Machinify a manage conformity SaaS health plan offering partners where expansion combination our specialties that model, sold areas Evolent allows our cover solution an other and on general do
technology to approach anticipate within the At as we the measured capitalization moment, engineering a the our rate resources this of current lower that implementation do integration. development start we we're a of budget taking
we We $XX million up this in continue the excited we from of target and believe the impact the about in come. to will potential it the annualized to years to improvement EBITDA as have technology be solution
Looking same. remain capital ahead, priorities the our
accelerate We business, growth. and a sheet our ratio accretive prudent in strategic at the leverage out and maintain continue to seek maximize strong balance that to assets flexibility reinvest financial platform
as an we the the topic front call on and Before address November. election take I John, this we're since on issues get few in closer more I policy to to will year, a hand oxygen want to
Further, of and lower any and burdens model. which aisle. quality by more support from In patient providers the our from those value engagement management short, utilization obviously is management we of focus drives we're enjoyed enduring our the higher condition reduces and navigation theme believe on both keeping on provider our further the on sides has model cost, always of
ahead. gave go actions percentage we over will believe examples data, time In fact, the other XX% oncology, on estimate based and our we the in earlier in up of outside traditional creation value that utilization comes and of management, that we from
the turn I'll call that, over to With John.
